Antibody response to symptomatic infection with SARS-CoV-2 Omicron variant viruses, December 2021-June 2022

Ryan Sandford1,2,3, Ruchi Yadav1, Emma K Noble1,2

  • 1Centers for Disease Control and Prevention, Atlanta, GA, USA.